相关实验视频

Updated: Jan 14, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

重新思考ALS:当前的理解和新兴的治疗策略

Arosh S Perera Molligoda Arachchige¹

¹Faculty of Medicine, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Lombardy, Italy.

AIMS neuroscience

|October 17, 2025

概括

肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病. 目前的理解涵盖了病理生理学,危险因素和支持性治疗,但治愈仍然难以捉摸.

科学领域:

神经科学是一个神经科学.
神经学神经学
遗传学遗传学是一个

背景情况:

肌缩侧面硬化症 (ALS) 是一种渐进的运动神经元疾病.
确切的ALS的原因是未知的,但可能涉及遗传和环境因素.
目前的治疗方法提供了有限的益处,突出了进一步研究的必要性.

研究的目的:

总结一下目前对ALS的理解.
审查ALS病理生理学,流行病学,风险因素,临床表现和治疗策略.

主要方法:

文献综述和对ALS现有研究的综合.
对有关ALS病因和进展的当前知识进行分析.
概述可用的治疗干预措施及其有效性.

主要成果:

ALS涉及运动神经元退化,导致肌肉缩和呼吸衰竭.
关键的病理机制包括RNA代谢,线粒体功能障碍和谷氨酸毒性.
利鲁提供了适度的生存益处,但支持性护理是主要的.

结论:

尽管在了解ALS方面取得了进展,但有效的治疗方法仍然有限.
对ALS病理生理学的进一步研究对于开发治愈来说至关重要.
对于患有ALS的患者来说,全面的管理策略至关重要.

关键词:

RNA代谢的RNA代谢过程里卢醇是一种可靠的药物.骨髓缩侧面硬化症 (ALS) 是一种运动神经元疾病运动神经元疾病神经退行症的神经退行症

更多相关视频

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Autism Spectrum Disorder

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Modeling in Therapy

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...